Skip to content

Opening book details…

About this Medicine article

Imatinib Mesylate Discontinuation in Patients with Chronic Myeloid Leukemia Who Have Received Front-line Imatinib Mesylate Therapy and Achieved Complete Molecular Response by Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Chang-Yeol Yim; So Yeon Jeon; Seunghwan Shin; Jeong-A Kim; Hee Sun Kim; Eun Hae Cho; Jae-Yong Kwak is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Chang-Yeol Yim; So Yeon Jeon; Seunghwan Shin; Jeong-A Kim; Hee Sun Kim; Eun Hae Cho; Jae-Yong Kwak
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0145-2126)
Published
2012
Language
EN
Field
Medicine (Health Sciences)

More by Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Chang-Yeol Yim; So Yeon Jeon; Seunghwan Shin; Jeong-A Kim; Hee Sun Kim; Eun Hae Cho; Jae-Yong Kwak

Browse all works by Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Chang-Yeol Yim; So Yeon Jeon; Seunghwan Shin; Jeong-A Kim; Hee Sun Kim; Eun Hae Cho; Jae-Yong Kwak